“…In a similar manner, peptide KKYNVPQL (a s1 -CN f(102-109)) exhibited a 10 fold greater inhibitory activity than KKYNVPQ (a s1 -CN f(102-108)) (IC 50 values 77.1 and 716.9 mm, respectively) which might be also caused by the presence of leucine as the C-terminal residue. Moreover, it is known that ACE only binds weakly with competitive peptide inhibitors that have penultimate proline residues (Cushman et al, 1973) (as occurs in KKYNVPQ) while, on the other hand, the presence of proline as antepenultimate residue (as occurs in KKYNVPQL) appears to enhance binding (Stevens, Micalizzi, Fessler, & Pals, 1972;Rohrbach, Williams, & Rolstad, 1981). Therefore, both the position of proline and the presence of leucine as the C-terminal residue in KKYNVPQL could explain the more potent activity exhibited by this peptide.…”